Reliq Historical Cash Flow
| RHT Stock | CAD 0.22 0.00 0.00% |
Analysis of Reliq Health cash flow over time is an excellent tool to project Reliq Health Technologies future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as End Period Cash Flow of 145.1 K or Stock Based Compensation of 6.7 M as it is a great indicator of Reliq Health ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Reliq Health Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Reliq Health Technologies is a good buy for the upcoming year.
Reliq |
About Reliq Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Reliq balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Reliq's non-liquid assets can be easily converted into cash.
Reliq Health Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Reliq Health Technologies to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Reliq Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Reliq Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Reliq Health Technologies current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reliq Health Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Reliq Health's Total Cash From Financing Activities is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 6.7 M in 2024, despite the fact that Free Cash Flow is likely to grow to (6.9 M).
| 2020 | 2021 | 2023 | 2024 (projected) | Depreciation | 125.8K | 115.3K | 132.6K | 167.2K | Stock Based Compensation | 4.4M | 5.5M | 6.3M | 6.7M |
Reliq Health cash flow statement Correlations
Click cells to compare fundamentals
Reliq Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Reliq Health cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (9.5M) | (332.2K) | 213.5K | (93.5K) | (84.2K) | (80.0K) | |
| Free Cash Flow | (12.0M) | (6.3M) | (7.1M) | (8.0M) | (7.2M) | (6.9M) | |
| Change In Working Capital | (452.4K) | 760.5K | 181.1K | (5.5M) | (4.9M) | (4.7M) | |
| Begin Period Cash Flow | 345.0K | 12.8K | 226.3K | 132.8K | 152.7K | 145.1K | |
| Other Cashflows From Financing Activities | (57.1K) | 40K | 4.4M | 144K | 165.6K | 157.3K | |
| Total Cash From Operating Activities | (12.0M) | (6.3M) | (7.1M) | (8.0M) | (7.2M) | (6.9M) | |
| Net Income | (13.0M) | (11.1M) | (11.8M) | (8.2M) | (7.4M) | (7.0M) | |
| Total Cash From Financing Activities | 2.5M | 5.6M | 7.3M | 7.9M | 9.1M | 9.6M | |
| End Period Cash Flow | 345.0K | 12.8K | 226.3K | 132.8K | 152.7K | 145.1K | |
| Other Non Cash Items | (504.2K) | 36.2K | 46.6K | (7.6K) | (6.8K) | (6.5K) | |
| Stock Based Compensation | 1.3M | 3.8M | 4.4M | 5.5M | 6.3M | 6.7M | |
| Change To Account Receivables | (208.8K) | (479.4K) | (1.1M) | (104.4K) | (93.9K) | (98.6K) | |
| Change To Operating Activities | 2.3M | (17.7K) | (47.3K) | 42.0K | 48.2K | 50.7K | |
| Change To Netincome | 962.9K | 3.7M | 4.4M | 5.5M | 6.3M | 6.6M | |
| Change To Liabilities | 569.4K | 288.9K | 817.9K | 1.5M | 1.8M | 1.9M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Reliq Stock Analysis
When running Reliq Health's price analysis, check to measure Reliq Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reliq Health is operating at the current time. Most of Reliq Health's value examination focuses on studying past and present price action to predict the probability of Reliq Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reliq Health's price. Additionally, you may evaluate how the addition of Reliq Health to your portfolios can decrease your overall portfolio volatility.